1. 1) World Health Organization. Member State mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit medical products. Report by the Director-General. The Seventieth World Health Assembly: provisional agenda item 13.6, WHA70/23, 2017.
2. 2) World Health Organization. “Substandard and falsified medical products. Fact sheet, 31 January, 2018.”: ‹https://www.who.int/news-room/fact-sheets/detail/substandard-and-falsified-medical-products›, accessed 13 September, 2023.
3. 3) World Health Organization. “WHO Global Surveillance and Monitoring System for substandard and falsified medical products, 2017.”: ‹http://who.int/entity/medicines/regulation/ssffc/publications/GSMS_Report.pdf›, accessed 13 September, 2023.
4. 4) Khan MH, Akazawa M, Dararath E, Kiet HB, Sovannarith T, Nivanna N, Yoshida N, Kimura K. Perceptions and practices of pharmaceutical wholesalers surrounding counterfeit medicines in a developing country: a baseline survey. BMC Health Serv. Res., 11, 306 (2011).
5. 5) Khan MH, Okumura J, Sovannarith T, Nivanna N, Nagai H, Taga M, Yoshida N, Akazawa M, Tanimoto T, Kimura K. Counterfeit medicines in Cambodia—possible causes. Pharm. Res., 28, 484–489 (2011).